Thanks for your analysis on this. It maybe helpful. I think you missed one possibility and that is that some (big)pharm is trying to sufficate GTCB on their hunt to take over the IP for a nickle. It's hard to believe this scenario will take place, if you think of Genzyme's role and the partnership with LFB, not to mention the other strategic partnerships. Maybe Dew should organize a new quiz based on the choices that Crou offers in his analysis. My bet: option 5 will be the winner... And nobody likes that.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.